{{Rsnum
|rsid=3939286
|Chromosome=9
|position=6210099
|Orientation=minus
|GMAF=0.2447
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 42.5 | 50.4
| HCB | 0.7 | 7.3 | 92.0
| JPT | 0.0 | 4.4 | 95.6
| YRI | 32.7 | 44.9 | 22.4
| ASW | 26.3 | 43.9 | 29.8
| CHB | 0.7 | 7.3 | 92.0
| CHD | 1.8 | 3.7 | 94.5
| GIH | 5.0 | 36.6 | 58.4
| LWK | 25.5 | 51.8 | 22.7
| MEX | 8.6 | 20.7 | 70.7
| MKK | 17.4 | 46.5 | 36.1
| TSI | 4.0 | 35.6 | 60.4
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3939286
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19198610
|Annotation=The SNP at 9q24, close to IL33, that showed suggestive association with eosinophil counts was also associated with atopic asthma (P = 2.2 x 10(-5)).
|Drugs=
|Drug Classes=
|Diseases=Asthma
|Curation Level=Curated
|PharmGKB Accession ID=PA163522162
}}

{{PMID Auto
|PMID=19860791
|Title=Genetic evidence for a role of IL33 in nasal polyposis.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3939286
|overall_frequency_n=81
|overall_frequency_d=126
|overall_frequency=0.642857
|n_genomes=44
|n_genomes_annotated=0
|n_haplomes=71
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=24468584
|Title=Impact of genetic polymorphisms on the pathogenesis of idiopathic achalasia: association with IL33 gene variant
}}

{{PMID Auto
|PMID=23028483
|Title=Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}